EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome
- Drosos, George C.
- Vedder, Daisy
- Houben, Eline
- Boekel, Laura
- Atzeni, Fabiola
- Badreh, Sara
- Boumpas, Dimitrios T.
- Brodin, Nina
- Bruce, Ian N.
- González-Gay, Miguel Ángel
- Jacobsen, Søren
- Kerekes, György
- Marchiori, Francesca
- Mukhtyar, Chetan
- Ramos-Casals, Manuel
- Sattar, Naveed
- Schreiber, Karen
- Sciascia, Savino
- Svenungsson, Elisabet
- Szekanecz, Zoltan
- Tausche, Anne-Kathrin
- Tyndall, Alan
- van Halm, Vokko
- Voskuyl, Alexandre
- Macfarlane, Gary
- Ward, Michael M.
- Nurmohamed, Michael T.
- Tektonidou, Maria G.
Publication date
May 2022
DOI Publisher
BMJ Journal
Annals of the Rheumatic Diseases Language
EnglishAbstract
Acknowledgements: The committee wishes to acknowledge the support of the EULAR Standing Committee on Clinical Affairs and the EULAR Secretariat. Funding: This study was funded by European Alliance of Associations for Rheumatology, EULAR. Project number: CLI112Peer reviewedPostprin
Add to ORKG